Market Overview

Cosmos Holdings Inc. Enters Into Share Exchange Agreement With Marathon Global Inc. and Kaneh Bosm BioTechnology Inc.


CHICAGO, July 24, 2018 (GLOBE NEWSWIRE) -- Cosmos Holdings Inc. (the "Company") (OTCQB:COSM), an international pharmaceutical company, announced a share exchange agreement with Marathon Global Inc. and Kaneh Bosm BioTechnology Inc. (CSE:KBB) ("Kaneh Bosm").

Cosmos Holdings Inc. completed a share exchange agreement by and among Marathon Global Inc. and Kaneh Bosm. The Company has transferred its interest in Marathon Global Inc. for an aggregate 10 million shares of Kaneh Bosm. Completion of the share exchange agreement was subject to satisfaction of various conditions precedent all of which have been satisfied. The 10 million shares of Kaneh Bosm owned by Cosmos Holdings constitute approximately 7% of the 141,219,108 shares of capital stock of Kaneh Bosm issued and outstanding.

As part of the share exchange agreement, Cosmos Holdings will procure and distribute Marathon Global's medical cannabis products and all cannabis derivatives for clients of Cosmos in approved countries within its distribution network of 160 clients, representing approximately 35,000 pharmacies in 16 countries.

Cosmos Holdings CEO Gregory Siokas commented, "I am pleased to announce this agreement will provide Cosmos with additional product lines, all of which we anticipate will increase revenues and profitability on a global scale. Our sales teams are already familiarizing themselves with the new product line and disseminating the details to our global clients."

About Cosmos Holdings Inc.
Cosmos Holdings Inc. is a pharmaceutical wholesaler with offices and warehouses in Thessaloniki, Greece and in Harlow, UK. The Company has a trans-European network of over 160 clients and vendors which expands to 16 countries including: Germany, United Kingdom, Ireland, United Arab Emirates, Denmark, Italy, France, Singapore, Spain, Lebanon, Skopje, Jordan, Sweden, Poland, Netherlands, and Greece. More information is available at

About Kaneh Bosm:
Kaneh Bosm (CSE:KBB) specializes in the acquisition of marijuana projects and cannabis related companies. The Company, through its subsidiaries, has agreements in place for European-based pharmaceutical distribution, working interests in industrial hemp licenses in Greece, licenses to cultivate, produce, hold, sell and export cannabis and its by-products in Colombia and the Kingdom of Lesotho, Africa.

Kahen Bosm is listed on the Canadian Securities Exchange ("CSE") and its common shares trade under the ticker symbol "KBB". Additional information relating to the Company is available on SEDAR at and on the CSE at

Except for historical information, this news release contains forward-looking statements, within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These statements involve unknown risks, and uncertainties that may cause the Company's actual results or outcomes to be materially different from those anticipated and discussed herein. Important factors that might cause such differences are discussed in the Company's filings with the Securities and Exchange Commission. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Actual results could differ materially from those anticipated in these forward-looking statements, if new information becomes available in the future.

Investor Relations Contact
Andrew Barwicki
Tel: 516-662-9461 /

View Comments and Join the Discussion!